1 712

Cited 39 times in

The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.

DC Field Value Language
dc.contributor.author양승철-
dc.contributor.author이영훈-
dc.contributor.author조강수-
dc.contributor.author조남훈-
dc.contributor.author최영득-
dc.contributor.author홍성준-
dc.date.accessioned2015-04-24T17:01:31Z-
dc.date.available2015-04-24T17:01:31Z-
dc.date.issued2009-
dc.identifier.issn0042-1138-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/104616-
dc.description.abstractPURPOSE: We evaluated the incidence and risk factors for urethral recurrence following radical cystectomy and urinary diversion in transitional cell carcinoma. PATIENTS AND METHODS: A retrospective review was performed of the 412 consecutive patients who underwent radical cystectomy and urinary diversion for transitional cell carcinoma of the bladder between 1986 and 2004. A total of 294 patients were enrolled in this study. We investigated the impact of various clinical and pathological features on urethral recurrence by univariate and multivariate analysis. RESULTS: Urethral recurrence developed in 13 patients (4.4%) and the 5-year urethral recurrence-free probability was 94.9%. On univariate analysis, positive urethral margin, prostatic stromal invasion, and prostatic urethral involvement had a significant influence on urethral recurrence (p < 0.05). The other clinical and pathological features were not significantly associated with urethral recurrence (p > 0.05). A multivariate Cox proportional hazard model revealed that a positive urethral margin (hazards ratio (HR) = 18.33, p < 0.001), prostatic urethral involvement (HR = 7.95, p < 0.001), and prostatic stromal invasion (HR = 5.80, p = 0.018) were independent risk factors for urethral recurrence. CONCLUSION: A positive urethral margin is considered an absolute indication for prophylactic urethrectomy. In addition, more careful patient selection is necessary for orthotopic urinary diversion in patients with prostatic urethral involvement and prostatic stromal invasion.-
dc.description.statementOfResponsibilityopen-
dc.format.extent306~311-
dc.relation.isPartOfUROLOGIA INTERNATIONALIS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCarcinoma, Transitional Cell/epidemiology-
dc.subject.MESHCarcinoma, Transitional Cell/pathology-
dc.subject.MESHCarcinoma, Transitional Cell/surgery*-
dc.subject.MESHCystectomy*-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHHumans-
dc.subject.MESHIncidence-
dc.subject.MESHKaplan-Meier Estimate-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Invasiveness-
dc.subject.MESHNeoplasm Recurrence, Local/epidemiology-
dc.subject.MESHNeoplasm Recurrence, Local/prevention & control*-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHPatient Selection-
dc.subject.MESHProportional Hazards Models-
dc.subject.MESHProstate/pathology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Assessment-
dc.subject.MESHRisk Factors-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUrethra/pathology*-
dc.subject.MESHUrethral Neoplasms/epidemiology-
dc.subject.MESHUrethral Neoplasms/pathology-
dc.subject.MESHUrethral Neoplasms/prevention & control*-
dc.subject.MESHUrinary Bladder Neoplasms/epidemiology-
dc.subject.MESHUrinary Bladder Neoplasms/pathology-
dc.subject.MESHUrinary Bladder Neoplasms/surgery*-
dc.subject.MESHUrinary Diversion*-
dc.titleThe risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Urology (비뇨기과학)-
dc.contributor.googleauthorKang Su Cho-
dc.contributor.googleauthorJoo Wan Seo-
dc.contributor.googleauthorSung Jin Park-
dc.contributor.googleauthorYoung Hoon Lee-
dc.contributor.googleauthorYoung Deuk Choi-
dc.contributor.googleauthorNam Hoon Cho-
dc.contributor.googleauthorSeung Choul Yang-
dc.contributor.googleauthorSung Joon Hong-
dc.identifier.doi10.1159/000209363-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02294-
dc.contributor.localIdA02969-
dc.contributor.localIdA03801-
dc.contributor.localIdA03812-
dc.contributor.localIdA04111-
dc.contributor.localIdA04402-
dc.relation.journalcodeJ02773-
dc.identifier.eissn1423-0399-
dc.identifier.pmid19440019-
dc.identifier.urlhttp://www.karger.com/Article/FullText/209363-
dc.subject.keywordBladder cancer-
dc.subject.keywordCystectomy-
dc.subject.keywordTransitional cell carcinoma-
dc.contributor.alternativeNameYang, Seung Choul-
dc.contributor.alternativeNameLee, Young Hoon-
dc.contributor.alternativeNameCho, Kang Su-
dc.contributor.alternativeNameCho, Nam Hoon-
dc.contributor.alternativeNameChoi, Young Deuk-
dc.contributor.alternativeNameHong, Sung Joon-
dc.contributor.affiliatedAuthorYang, Seung Choul-
dc.contributor.affiliatedAuthorLee, Young Hoon-
dc.contributor.affiliatedAuthorCho, Kang Su-
dc.contributor.affiliatedAuthorCho, Nam Hoon-
dc.contributor.affiliatedAuthorChoi, Young Deuk-
dc.contributor.affiliatedAuthorHong, Sung Joon-
dc.citation.volume82-
dc.citation.number3-
dc.citation.startPage306-
dc.citation.endPage311-
dc.identifier.bibliographicCitationUROLOGIA INTERNATIONALIS, Vol.82(3) : 306-311, 2009-
dc.identifier.rimsid52814-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.